{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T09:59:30Z","timestamp":1693303170132},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,9,1]]},"DOI":"10.2146\/ajhp100473","type":"journal-article","created":{"date-parts":[[2011,8,19]],"date-time":"2011-08-19T16:09:55Z","timestamp":1313770195000},"page":"1607-1614","source":"Crossref","is-referenced-by-count":4,"title":["Pharmacokinetics of aminoglycosides in patients with chronic spinal cord injury"],"prefix":"10.1093","volume":"68","author":[{"given":"Flora","family":"Young","sequence":"first","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, at the time of writing"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary H. H.","family":"Ensom","sequence":"additional","affiliation":[{"name":"Doctor of Pharmacy Program, Faculty of Pharmaceutical Sciences, University of British Columbia, and Clinical Pharmacy Specialist, Children\u2019s and Women\u2019s Health Centre of British Columbia, Vancouver"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"key\n\t\t\t\t2019041106061319400_b1-0681607","article-title":"Rehabilitation","volume-title":"Current diagnosis and treatment in orthopedics","author":"Keenan","year":"2006","edition":"4th ed"},{"key":"key\n\t\t\t\t2019041106061319400_b2-0681607","unstructured":"National Spinal Cord Injury Statistical Center. Spinal cord injury facts and figures at a glance. https:\/\/www.nscisc.uab.edu\/public_content\/pdf\/Facts%20and%20Figures%20at%20a%20Glance%202010.pdf (accessed 2010 May 16)."},{"key":"key\n\t\t\t\t2019041106061319400_b3-0681607","unstructured":"Abrams GM Wakasa M . Chronic complications of spinal cord injury. In: BasowDS, ed. UpToDate. www.uptodate.com\/patients\/content\/topic.do?topicKey=~VwAwFq7EG6jGfV (accessed 2010 Mar 23)."},{"key":"key\n\t\t\t\t2019041106061319400_b4-0681607","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1056\/NEJM199402243300808","article-title":"Chronic spinal cord injury","volume":"330","author":"Ditunno","year":"1994","journal-title":"N Engl J Med."},{"key":"key\n\t\t\t\t2019041106061319400_b5-0681607","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2174\/1568016043477242","article-title":"Cardiovascular alterations after spinal cord injury: an overview","volume":"2","author":"Bravo","year":"2004","journal-title":"Curr Med Chem Cardiovasc Hematol Agents."},{"key":"key\n\t\t\t\t2019041106061319400_b6-0681607","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/PHM.0b013e31802f0247","article-title":"Cardiovascular disease in spinal cord injury: an overview of prevalence, risk, evaluation, and management","volume":"86","author":"Myers","year":"2007","journal-title":"Am J Phys Med Rehabil."},{"key":"key\n\t\t\t\t2019041106061319400_b7-0681607","article-title":"Spinal cord injury: the role of pharmacokinetics in optimizing drug therapy","volume-title":"Spinal cord medicine: principles and practice","author":"Richardson","year":"2003"},{"issue":"(suppl 1)","key":"key\n\t\t\t\t2019041106061319400_b8-0681607","doi-asserted-by":"crossref","first-page":"S183","DOI":"10.1007\/s00592-003-0061-7","article-title":"Body composition assessment in spinal cord injury subjects","volume":"40","author":"Maggioni","year":"2003","journal-title":"Acta Diabetol."},{"key":"key\n\t\t\t\t2019041106061319400_b9-0681607","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1152\/japplphysiol.00729.2002","article-title":"Factors influencing body composition in persons with spinal cord injury: a cross-sectional study","volume":"95","author":"Spungen","year":"2003","journal-title":"J Appl Physiol."},{"key":"key\n\t\t\t\t2019041106061319400_b10-0681607","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0003-9993(03)00045-5","article-title":"Healthy body mass index values often underestimate body fat in men with spinal cord injury","volume":"84","author":"Jones","year":"2003","journal-title":"Arch Phys Med Rehabil."},{"key":"key\n\t\t\t\t2019041106061319400_b11-0681607","first-page":"418","article-title":"Pharmacokinetics of gentamicin in patients with spinal cord injury","volume":"3","author":"Segal","year":"1984","journal-title":"Clin Pharm."},{"key":"key\n\t\t\t\t2019041106061319400_b12-0681607","first-page":"47","article-title":"Gentamicin disposition kinetics in humans with spinal cord injury","volume":"23","author":"Segal","year":"1985","journal-title":"Paraplegia."},{"key":"key\n\t\t\t\t2019041106061319400_b13-0681607","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/j.1875-9114.1988.tb03539.x","article-title":"Amikacin pharmacokinetics in patients with spinal cord injury","volume":"8","author":"Segal","year":"1988","journal-title":"Pharmacotherapy."},{"key":"key\n\t\t\t\t2019041106061319400_b14-0681607","doi-asserted-by":"crossref","first-page":"PL1","DOI":"10.1016\/0024-3205(91)90030-F","article-title":"Amikacin serum protein binding in spinal cord injury","volume":"49","author":"Brunnemann","year":"1991","journal-title":"Life Sci"},{"key":"key\n\t\t\t\t2019041106061319400_b15-0681607","first-page":"961","article-title":"Impaired absorption of intramuscularly administered gentamicin in spinal cord injury","volume":"39","author":"Segal","year":"1986","journal-title":"Curr Ther Res."},{"key":"key\n\t\t\t\t2019041106061319400_b16-0681607","first-page":"540","article-title":"Serum gentamicin levels in traumatic paraplegics following intramuscular administration in non- paralyzed limbs","volume":"27","author":"Sankaranarayanan","year":"1989","journal-title":"Int J Clin Pharmacol Ther Toxicol."},{"key":"key\n\t\t\t\t2019041106061319400_b17-0681607","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1177\/106002808802200603","article-title":"Gentamicin bioavailability and single-dose pharmacokinetics in spinal cord injury","volume":"22","author":"Segal","year":"1988","journal-title":"Drug Intell Clin Pharm."},{"key":"key\n\t\t\t\t2019041106061319400_b18-0681607","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1177\/00912700122010221","article-title":"A dose-ranging study of gentamicin pharmacokinetics: implications for extended-interval aminoglycoside therapy","volume":"41","author":"McNamara","year":"2001","journal-title":"J Clin Pharmacol."},{"key":"key\n\t\t\t\t2019041106061319400_b19-0681607","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/sj.sc.3100975","article-title":"Dosage of once-daily gentamicin in spinal cord injury patients","volume":"38","author":"Vaidyanathan","year":"2000","journal-title":"Spinal Cord."},{"key":"key\n\t\t\t\t2019041106061319400_b20-0681607","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron."},{"key":"key\n\t\t\t\t2019041106061319400_b21-0681607","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1100\/tsw.2006.44","article-title":"Amikacin dosing and monitoring in spinal cord injury patients: variation in clinical practice between spinal injury units and differences in experts\u2019 recommendations","volume":"6","author":"Vaidyanathan","year":"2006","journal-title":"ScientificWorldJournal."},{"key":"key\n\t\t\t\t2019041106061319400_b22-0681607","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.clinbiochem.2006.10.014","article-title":"How to estimate GFR-serum creatinine, serum cystatin C or equations","volume":"40","author":"Herget-Rosenthal","year":"2007","journal-title":"Clin Biochem."},{"key":"key\n\t\t\t\t2019041106061319400_b23-0681607","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1681\/ASN.2009020171","article-title":"Measured GFR as a confirmatory test for estimated GFR","volume":"20","author":"Stevens","year":"2009","journal-title":"J Am Soc Nephrol."},{"key":"key\n\t\t\t\t2019041106061319400_b24-0681607","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1345\/aph.1H586","article-title":"New serum creatinine assay standardization: implications for drug dosing","volume":"41","author":"Wade","year":"2007","journal-title":"Ann Pharmacother."},{"key":"key\n\t\t\t\t2019041106061319400_b25-0681607","first-page":"23","article-title":"Prediction of creatinine clearance from serum creatinine in spinal cord injury patients","volume":"21","author":"Mirahmadi","year":"1983","journal-title":"Paraplegia."},{"key":"key\n\t\t\t\t2019041106061319400_b26-0681607","first-page":"237","article-title":"Accuracy of formula-derived creatinine clearance in paraplegic subjects","volume":"47","author":"Thakur","year":"1997","journal-title":"Clin Nephrol."},{"key":"key\n\t\t\t\t2019041106061319400_b27-0681607","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S0022-5347(17)42606-1","article-title":"Creatinine clearance prediction in spinal cord injury patients: comparison of 6 prediction equations","volume":"139","author":"Mohler","year":"1988","journal-title":"J Urol."},{"key":"key\n\t\t\t\t2019041106061319400_b28-0681607","first-page":"160","article-title":"Serum creatinine in patients with spinal cord injury","volume":"57","author":"Kaji","year":"1990","journal-title":"Mt Sinai J Med."},{"key":"key\n\t\t\t\t2019041106061319400_b29-0681607","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1046\/j.1464-410x.2000.00680.x","article-title":"Monitoring of renal function in patients with spinal cord injury","volume":"85","author":"MacDiarmid","year":"2000","journal-title":"BJU Int."},{"key":"key\n\t\t\t\t2019041106061319400_b30-0681607","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1515\/CCLM.2008.336","article-title":"Cystatin C: current position and future prospects","volume":"46","author":"S\u00e9ronie-Vivien","year":"2008","journal-title":"Clin Chem Lab Med."},{"key":"key\n\t\t\t\t2019041106061319400_b31-0681607","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/01.mnh.0000247505.71915.05","article-title":"Serum cystatin C as a marker of glomerular filtration rate","volume":"15","author":"Madero","year":"2006","journal-title":"Curr Opin Nephrol Hypertens."},{"key":"key\n\t\t\t\t2019041106061319400_b32-0681607","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1258\/0004563021901847","article-title":"Cystatin C","volume":"39","author":"Newman","year":"2002","journal-title":"Ann Clin Biochem."},{"key":"key\n\t\t\t\t2019041106061319400_b33-0681607","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1053\/j.ajkd.2006.07.001","article-title":"GFR estimation using cystatin C is not independent of body composition","volume":"48","author":"Macdonald","year":"2006","journal-title":"Am J Kidney Dis."},{"key":"key\n\t\t\t\t2019041106061319400_b34-0681607","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1007\/s00467-007-0535-x","article-title":"Effect of malnutrition on serum creatinine and cystatin C levels","volume":"22","author":"Hari","year":"2007","journal-title":"Pediatr Nephrol."},{"key":"key\n\t\t\t\t2019041106061319400_b35-0681607","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1542\/peds.58.2.259","article-title":"A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine","volume":"58","author":"Schwartz","year":"1976","journal-title":"Pediatrics."},{"key":"key\n\t\t\t\t2019041106061319400_b36-0681607","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.clinbiochem.2006.10.026","article-title":"Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children\u2014a meta-analysis","volume":"40","author":"Roos","year":"2007","journal-title":"Clin Biochem."},{"key":"key\n\t\t\t\t2019041106061319400_b37-0681607","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0022-5347(17)44870-1","article-title":"The evaluation of creatinine clearance in spinal cord injury patients","volume":"136","author":"Mohler","year":"1986","journal-title":"J Urol."},{"key":"key\n\t\t\t\t2019041106061319400_b38-0681607","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.apmr.2005.11.032","article-title":"Role of creatinine clearance as a screening test in persons with spinal cord injury","volume":"87","author":"Sepahpanah","year":"2006","journal-title":"Arch Phys Med Rehabil."},{"key":"key\n\t\t\t\t2019041106061319400_b39-0681607","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/sj.sc.3101320","article-title":"Serum cystatin C as a marker of the renal function in patients with spinal cord injury","volume":"40","author":"Thomassen","year":"2002","journal-title":"Spinal Cord."},{"key":"key\n\t\t\t\t2019041106061319400_b40-0681607","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate form serum creatinine: a new prediction equation","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med."},{"key":"key\n\t\t\t\t2019041106061319400_b41-0681607","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1258\/000456303766476995","article-title":"Cystatin C for estimation of glomerular filtration rate in patients with spinal cord injury","volume":"40","author":"Jenkins","year":"2003","journal-title":"Ann Clin Biochem."},{"key":"key\n\t\t\t\t2019041106061319400_b42-0681607","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/MJT.0b013e3181a75c84","article-title":"Single-dose gentamicin clearance is a predictor of creatinine clearance in spinal man","volume":"17","author":"Segal","year":"2010","journal-title":"Am J Ther."},{"key":"key\n\t\t\t\t2019041106061319400_b43-0681607","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0022-5347(17)44870-1","article-title":"The evaluation of creatinine clearance in spinal cord injury patients","volume":"136","author":"Mohler","year":"1986","journal-title":"J Urol."},{"key":"key\n\t\t\t\t2019041106061319400_b44-0681607","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/cpt1977213362","article-title":"Kinetic model for gentamicin dosing with the use of individual patient parameters","volume":"3","author":"Sawchuk","year":"1977","journal-title":"Clin Pharmacol Ther."},{"key":"key\n\t\t\t\t2019041106061319400_b45-0681607","unstructured":"Davis GA Lewis DA , eds. Clinical pharmacokinetics service and anticoagulation guidelines, 31st ed. www.hosp.uky.edu\/pharmacy\/cps\/PKmanual-disclaimer.html (accessed 2010 Nov 16)."}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/68\/17\/1607\/28349889\/ajhp1607.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T22:02:28Z","timestamp":1686261748000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/68\/17\/1607\/5129210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,1]]},"references-count":45,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2011,9,1]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp100473","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2011,9,1]]},"published":{"date-parts":[[2011,9,1]]}}}